Cargando…
Ablation of atrial fibrillation: a procedure come of age?
Various approaches for catheter ablation of focal initiators of atrial fibrillation or the substrate for maintaining atrial fibrillation have evolved over the past 5 years. Despite these advances, there are still a large number of unresolved issues regarding the efficacy and safety of these procedur...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59627/ https://www.ncbi.nlm.nih.gov/pubmed/11806775 http://dx.doi.org/10.1186/cvm-2-2-067 |
| _version_ | 1782120088848039936 |
|---|---|
| author | Wharton, J Marcus |
| author_facet | Wharton, J Marcus |
| author_sort | Wharton, J Marcus |
| collection | PubMed |
| description | Various approaches for catheter ablation of focal initiators of atrial fibrillation or the substrate for maintaining atrial fibrillation have evolved over the past 5 years. Despite these advances, there are still a large number of unresolved issues regarding the efficacy and safety of these procedures as well as optimal patient selection for the different approaches. These uncertainties raise questions about the applicability at the present time of atrial fibrillation as front-line therapy within the community. |
| format | Text |
| id | pubmed-59627 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2001 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-596272001-11-06 Ablation of atrial fibrillation: a procedure come of age? Wharton, J Marcus Curr Control Trials Cardiovasc Med Commentary Various approaches for catheter ablation of focal initiators of atrial fibrillation or the substrate for maintaining atrial fibrillation have evolved over the past 5 years. Despite these advances, there are still a large number of unresolved issues regarding the efficacy and safety of these procedures as well as optimal patient selection for the different approaches. These uncertainties raise questions about the applicability at the present time of atrial fibrillation as front-line therapy within the community. BioMed Central 2001 2001-04-05 /pmc/articles/PMC59627/ /pubmed/11806775 http://dx.doi.org/10.1186/cvm-2-2-067 Text en Copyright © 2001 BioMed Central Ltd |
| spellingShingle | Commentary Wharton, J Marcus Ablation of atrial fibrillation: a procedure come of age? |
| title | Ablation of atrial fibrillation: a procedure come of age? |
| title_full | Ablation of atrial fibrillation: a procedure come of age? |
| title_fullStr | Ablation of atrial fibrillation: a procedure come of age? |
| title_full_unstemmed | Ablation of atrial fibrillation: a procedure come of age? |
| title_short | Ablation of atrial fibrillation: a procedure come of age? |
| title_sort | ablation of atrial fibrillation: a procedure come of age? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59627/ https://www.ncbi.nlm.nih.gov/pubmed/11806775 http://dx.doi.org/10.1186/cvm-2-2-067 |
| work_keys_str_mv | AT whartonjmarcus ablationofatrialfibrillationaprocedurecomeofage |